Aimo Kannt is Head of Drug Discovery and Preclinical Research at the Fraunhofer Institute for Translational Medicine and Pharmacology. An experienced drug hunter, he worked in various roles in pharmaceutical R&D in the fields of lead discovery, cardiovascular and metabolic diseases before joining Fraunhofer in 2020. He is a biochemist by training and teaches pharmacology at Frankfurt and Heidelberg University Medical Schools.
